RT Journal Article
SR Electronic
T1 Diet-derived fruit and vegetable metabolites suggest sex-specific mechanisms conferring protection against osteoporosis in humans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19003848
DO 10.1101/19003848
A1 Mangano, Kelsey M.
A1 Noel, Sabrina E.
A1 Lai, Chao-Qiang
A1 Christensen, Jacob J.
A1 Ordovas, Jose M.
A1 Dawson-Hughes, Bess
A1 Tucker, Katherine L.
A1 Parnell, Laurence D.
YR 2019
UL http://medrxiv.org/content/early/2019/08/15/19003848.abstract
AB The impact of nutrition on the metabolic profile of osteoporosis is incompletely characterized. The objective of this cross-sectional study was to detangle the association of fruit and vegetable (FV) intakes with osteoporosis prevalence. Dietary, anthropometric and blood plasma metabolite data were examined from the Boston Puerto Rican Osteoporosis Study, a cohort of 600 individuals (age 46-79yr). High FV intake was protective against osteoporosis prevalence. Associations of 525 plasma metabolites were assessed with fruit and vegetable intake, and separately with osteoporosis status. Several biological processes affiliated with the FV-associating metabolites, including caffeine metabolism, carnitines and fatty acids, and glycerophospholipids. For osteoporosis-associated metabolites, important processes were steroid hormone biosynthesis in women, and branched-chain amino acid metabolism in men. In all instances, the metabolite patterns differed greatly between sexes, arguing for a stratified nutrition approach in recommending FV intakes to improve bone health. Factors derived from principal components analysis of the FV intakes were correlated with the osteoporosis-associated metabolites, with high intake of dark leafy greens and berries/melons appearing protective in both sexes. These data warrant investigation into whether increasing intakes of dark leafy greens, berries and melons causally affect bone turnover and BMD among adults at risk for osteoporosis via sex-specific metabolic pathways, and how gene-diet interactions alter these sex-specific metabolomic-osteoporosis links.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01231958Funding StatementThis study was funded by the National Heart, Lung, and Blood Institute grant P50-HL105185; National Institute on Aging grants P01-AG023394 and R01-AG055948; K01 DK107804; a Mentored Career Development award NIH/NIAMS K01-AR067894 (to SEN), and by the US Department of Agriculture, under agreement number 8050-51000-098-00D.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.AUCarea under the curveBCAAbranched-chain amino acidBPRHSBoston Puerto Rican Health StudyBPROSBoston Puerto Rican Osteoporosis StudyDHAdocosahexaenoic acidDPAdocosahexaenoic acidECEnzyme CommissionEPAeicosapentaenoic acidFDRfalse discovery rateFFQfood frequency questionnaireFVfruit and vegetableKEGGKyoto Encyclopedia of Genes and GenomesNSAIDnonsteroidal anti-inflammatory drugOSosteoporosisPCAprincipal components analysisPUFApoly-unsaturated fatty acidsUSDAUnited States Department of Agriculture